Evaluation of [ ⁶⁸ Ga]Ga-DOTA-AeK as a Potential Imaging Tool for PET Imaging of Cell Wall Synthesis in Bacterial Infections.

Autor: Koatale PC; Department of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa., Welling MM; Department of Radiology, Interventional Molecular Imaging Laboratory, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Mdanda S; Department of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa., Mdlophane A; Department of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa., Takyi-Williams J; Therapeutics Systems Research Laboratories (TSRL), Inc., Ann Arbor, MI 48109, USA., Durandt C; Department of Medical Immunology, Institute for Cellular and Molecular Medicine, University of Pretoria, Pretoria 0001, South Africa.; South African Medical Research Council Extramural Unit for Stem Cell Research and Therapy, University of Pretoria, Pretoria 0001, South Africa., van den Bout I; Department of Physiology, University of Pretoria, Pretoria 0001, South Africa., Cleeren F; Department of Pharmacy and Pharmacological Sciences, Radiopharmaceutical Research, KU Leuven, 3000 Leuven, Belgium., Sathekge MM; Department of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa., Ebenhan T; Department of Nuclear Medicine, University of Pretoria, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.

Publikováno v: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2024 Aug 31; Vol. 17 (9). Date of Electronic Publication: 2024 Aug 31.

COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks.

Autor: Kgatle MM; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria, South Africa.; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, South Africa., Lawal IO; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria, South Africa.; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, South Africa.; Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria, South Africa., Mashabela G; SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, DSI/NRF Centre of Excellence for Biomedical TB Research, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Boshomane TMG; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria, South Africa.; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, South Africa.; Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria, South Africa.; Nuclear and Oncology Division, AXIM Medical (Pty), Midrand., Koatale PC; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria, South Africa.; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, South Africa., Mahasha PW; Precision Medicine and SAMRC Genomic Centre, Grants, Innovation, and Product Development (GIPD) Unit, South African Medical Research Council, Pretoria, South Africa., Ndlovu H; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, South Africa., Vorster M; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, South Africa., Rodrigues HG; Laboratory of Nutrients and Tissue Repair, School of Applied Sciences, University of Campinas, Campinas, Brazil., Zeevaart JR; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria, South Africa.; South African Nuclear Energy Corporation, Radiochemistry and NuMeRI PreClinical Imaging Facility, Mahikeng, South Africa.; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan City, Taiwan., Gordon S; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom., Moura-Alves P; Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Sathekge MM; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria, South Africa.; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria, South Africa.; SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, DSI/NRF Centre of Excellence for Biomedical TB Research, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Oct 08; Vol. 12, pp. 752380. Date of Electronic Publication: 2021 Oct 08 (Print Publication: 2021).